Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
Mepolizumab 100 MG Injection [Nucala]
DRUG
2 trials
Sponsors
Sotiria General Hospital
, Azienda Ospedaliero Universitaria di Cagliari
Conditions
EGPA - Eosinophilic Granulomatosis With Polyangiitis
Eosinophilic Asthma
Severe Asthma
Severe Eosinophilic Asthma
Phase 4
Beyond EOsinophils: proteoMICS to Identify Potential Biomarker of Organ Damage and Response to MEPOLIZUMAB in EGPA
Enrolling by invitation
NCT07343661
Azienda Ospedaliero Universitaria di Cagliari
EGPA - Eosinophilic Granulomatosis With Polyangiitis, Eosinophilic Asthma, Severe Asthma
Start: 2025-10-17
End: 2028-09-30
Target: 90
Updated: 2026-01-15
Unknown Phase
A Study on the Effect of Mepolizumab Therapy on Daily Physical Activity of Patients With Severe Eosinophilic Asthma
NCT03739320
Sotiria General Hospital
Severe Eosinophilic Asthma
Start: 2017-12-11
End: 2019-12-31
Target: 50
Updated: 2018-11-13